and another.....Morgans
AVITA Medical Inc (ASX: AVH)Morgans sees huge upside for this ASX share over the next 12 months. In fact, the broker believes the regenerative medicine company could more than double in value from current levels.
It was very pleased with news that the US FDA has approved its Recell Go product. It is an autologous cell harvesting device, harnessing the regenerative properties of a patient's own skin to treat burn wounds and full-thickness skin defects. It commented:
AVH has received FDA approval for its automated product, RECELL Go, for use in burns and full thickness skin defects. This approval marks a significant milestone for the company, with management expecting this device to increase adoption of the technology amongst clinicians. We have made no changes to our forecasts and recommendation.
Morgans has an add rating and $6.40 price target on its shares. This implies potential upside of 115% for investors.
Morningstar June 2024, page-2
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.46 |
Change
-0.050(1.99%) |
Mkt cap ! $163.1M | |||
| Open | High | Low | Value | Volume |
| $2.51 | $2.53 | $2.46 | $433.6K | 173.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 14387 | $2.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.50 | 109089 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |